Form DEFA14A CINTAS CORP
Tweet
Share
E-mail
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cintas (CTAS) PT Raised to $230 at UBS Following Q4 Results, Guidance
- EU Bans Fashion Waste; SMX Makes it New
- JCR Pharmaceuticals Receives Marketing Authorization in the United Arab Emirates for IZCARGO™, a Blood-Brain Barrier-Penetrating Enzyme Replacement Therapy for Hunter Syndrome
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
